KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

Lynx1 Capital Management LP's Holding History (CIK: 0001910456)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 1,981,106 Value ($000) $5,270 Avg Close — Range —
Q4 2023
Shares 1,997,006 Value ($000) $4,733 Avg Close — Range —
Q3 2023
Shares 1,997,006 Value ($000) $2,796 Avg Close — Range —
Q2 2023
Shares 2,048,736 Value ($000) $6,208 Avg Close — Range —
Q1 2023
Shares 2,214,250 Value ($000) $13,839 Avg Close — Range —
Q4 2022
Shares 1,998,417 Value ($000) $12,190 Avg Close — Range —
Q3 2022
Shares 1,674,677 Value ($000) $20,012 Avg Close — Range —
Q2 2022
Shares 1,674,677 Value ($000) $21,118 Avg Close — Range —
Q1 2022
Shares 692,508 Value ($000) $7,798 Avg Close — Range —